GOSS - Gossamer Bio Inc. (GOSS) CEO Faheem Hasnain on Q3 2021 Results - Earnings Call Transcript

Gossamer Bio, Inc. (GOSS) Q3 2021 Earnings Conference Call November 08, 2021, 16:15 ET Company Participants Bryan Giraudo - COO & CFO Faheem Hasnain - Co-Founder, CEO, President & Chairman Richard Aranda - Chief Medical Officer Conference Call Participants Yasmeen Rahimi - Piper Sandler & Co. Joseph Schwartz - SVB Leerink Carter Gould - Barclays Bank Olivia Brayer - Bank of America Merrill Lynch Presentation Operator Good day, and thank you for standing by. Welcome to the Gossamer Bio Q3 Earnings Call. [Operator Instructions]. I would now like to hand the conference over to your speaker today, Mr. Bryan Giraudo. Financial and Chief Operating Officer. Thank you. Please go ahead. Bryan Giraudo Thank you, operator, and thank you all for joining us this afternoon. I am joined on today's call by Gossamer Bio's Chairmen, Co-Founder, Chief Executive Officer, Faheem Hasnain; Laura Carter, Gossamer Bio's Chief Scientific Officer; and Richard Aranda,

For further details see:

Gossamer Bio, Inc. (GOSS) CEO Faheem Hasnain on Q3 2021 Results - Earnings Call Transcript